GX-03
GX-03 for COVID-19
Phase 2 small_molecule completed
Quick answer
GX-03 for Covid19 is a Phase 2 program (small_molecule) at Turn Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Turn Therapeutics
- Indication
- Covid19
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed